Raynaud Phenomenon
📧 Sign up to get email alerts when something new happens for Raynaud Phenomenon.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis [Phase 3]
Phase 3 trial evaluating sildenafil for improving microcirculatory blood flow and endothelial progenitor cell levels in systemic sclerosis h…
-
CLINICAL_TRIALS research · 2016-06-02Clinical Trial Update: Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis. [NA]
This completed clinical trial evaluates whether laser speckle contrast imaging can detect cutaneous microvascular dysfunction in systemic sc…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis [Phase 2]
A Phase 2 study evaluated acute peripheral vascular effects, safety and tolerability in patients with Raynaud's phenomenon secondary to syst…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: "As Required" Oral Sildenafil in Raynaud's Phenomenon [Phase 2, Phase 3]
A completed Phase 2/3 study evaluating as-needed oral sildenafil for Raynaud's Phenomenon has finished.
-
CLINICAL_TRIALS research · 2015-12-09Clinical Trial Update: PORH and Response to Cold in Raynaud's Phenomenon. [NA]
A clinical trial update investigating PORH (post-occlusive reactive hyperemia) and response to cold in Raynaud's phenomenon; the current stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-02-05Clinical Trial Update: Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon [Phase 1, Phase 2]
Phase 1/2 clinical trial to evaluate the safety and efficacy of Neovasculgen for secondary Raynaud's phenomenon; the status is unknown based…
-
FDA approval · 2015-01-11FDA Approved: NIFEDIPINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for nifedipine from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands [NA]
An update on a clinical trial assessing whether light rheography measurements can prognosticate outcomes in patients with secondary Raynaud'…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Tadalafil for the Treatment of Raynaud's [NA]
The trial evaluating tadalafil for Raynaud's phenomenon has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon [Phase 3]
Phase 3 clinical trial evaluating fasudil, a Rho-kinase inhibitor, for Raynaud's phenomenon (including scleroderma) has completed and posted…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon [Phase 2]
Phase 2 trial evaluating ORM-12741 for preventing Raynaud's phenomenon was terminated.
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator [Phase 2]
Phase 2 trial update evaluating a soluble guanylate cyclase stimulator to improve digital blood flow in Raynaud's phenomenon; the study has …
-
FDA approval · 2014-06-05FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Procardia XL (nifedipine) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Acupressure for the Treatment of Raynaud's Phenomenon [NA]
A completed clinical trial evaluating acupressure as a treatment for Raynaud's phenomenon. Conducted by the University of Michigan, the stud…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma [Phase 3]
A Phase 3 randomized trial evaluating tadalafil for Raynaud's phenomenon in patients with scleroderma has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon [Phase 2, Phase 3]
Clinical trial update reports results from Phase 2 and Phase 3 studies evaluating a PDE-5 inhibitor in combination with a calcium channel in…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison [Phase 1]
Phase 1 pharmacokinetic comparison of MQX-503 applied to the hand versus nitroglycerin ointment applied to the chest for Raynaud's Phenomeno…
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trials investigated the effect of vardenafil on clinical symptoms and peripheral blood flow in Raynaud's phenom…
-
CLINICAL_TRIALS research · 2010-07-20Clinical Trial Update: Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms [Phase 3]
Phase 3 clinical trial update for a topical formulation aimed at treating and preventing Raynaud's phenomenon symptoms; current status is un…
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma [Phase 3]
A Phase 3 randomized trial evaluated the efficacy of tadalafil for Raynaud's phenomenon and digital ulcers in systemic sclerosis; the study …
-
CLINICAL_TRIALS trial_result · 2009-07-27Clinical Trial Update: The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic Sclerosis [NA]
A completed clinical trial evaluated the effect of physical therapy on Raynaud's phenomenon in patients with systemic sclerosis.
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: St. John's Wort in the Treatment of Raynaud's Phenomenon [Phase 3]
A Phase 3 trial evaluating St. John's Wort for Raynaud's phenomenon has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon [Phase 1]
A Phase 1 trial evaluated the dose-response of topical glyceryl trinitrate in Raynaud's phenomenon. The study has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon [Phase 2]
A Phase 2 dose-response study evaluating a topical nitroglycerin formulation for Raynaud's phenomenon has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-30Clinical Trial Update: Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon [Phase 2]
Phase 2 dose-response clinical trial of a topical gel for Raynaud's phenomenon has completed. The study included participants with Raynaud's…